Other

Preferred Stock, Shares Issued

Bristol-Myers Squibb Preferred Stock, Shares Issued decreased by 12.5% to 2.5K in Q4 2025 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Preferred Stock, Shares Issued shows a downward trend with a -10.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025Feb 11, 2026

How to read this metric

A stable number indicates no new issuance or retirement of preferred stock, whereas changes reflect significant shifts in long-term financing strategy.

Detailed definition

This represents the total number of preferred stock shares that have been authorized and distributed by the company to s...

Peer comparison

Standard reporting metric across all public companies; usually compared against outstanding shares to determine treasury stock levels.

Metric ID: other_preferred_stock_shares_issued

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value3K2.9K2.5K
QoQ Change-2.9%-12.5%
YoY Change-2.9%-12.5%
Range2.5K3K
Avg YoY Growth-7.7%
Median YoY Growth-7.7%
Current Streak2+ quarters decline

Frequently Asked Questions

What is Bristol-Myers Squibb's preferred stock, shares issued?
Bristol-Myers Squibb (BMY) reported preferred stock, shares issued of 2.5K in Q4 2025.
What is the long-term trend for Bristol-Myers Squibb's preferred stock, shares issued?
Over 3 years (2020 to 2025), Bristol-Myers Squibb's preferred stock, shares issued has grown at a -10.4% compound annual growth rate (CAGR), from 3.5K to 2.5K.
What does preferred stock, shares issued mean?
The total number of preferred stock shares the company has created and distributed to investors.